Ionis Pharma’s Olezarsen Receives FDA Fast Track Designation for Familial Chylomicronemia Syndrome (FCS) Treatment
Ionis pharmaceuticals receives fast-track designation from U.S. Food and drug administration (FDA) for olezarsen in Familial chylomicronemia syndrome (FCS) treatment. Olezarsen (formerly IONIS-APOCIII ...